Skip to main content

中美冠科主办创新型线上AACR 2020会议和展会

Written by Customer Service on . Posted in Public Companies.

加州圣地亚哥, June 19, 2020 (GLOBE NEWSWIRE) — 中美冠科今天宣布了创新型线上AACR 2020会议。此次线上活动将于6月22至25日进行，集合了一个大型科学会议的所有要点。不仅拥有虚拟展位，还有来自冠科资深科学家的主题演讲，以及13张来自冠科AACR 2020的海报。
为了与AACR年度网络会议保持一致，在这个特别的论坛中，我们将展示由中美冠科内部及与其他机构合作的13张AACR 2020海报，包括了一系列临床前肿瘤学和免疫肿瘤学主题，包括肿瘤类器官和类器官工程、成像同基因与肿瘤同种移植，以及新型的人源化药物靶点模型，海报作者将在线回答问题。此次活动免费参加, 需要在CrownBio.com/AACR20上注册。主题剧场的亮点包括中美冠科首席科学官Henry Li博士的关于使用人源肿瘤类器官加速药物发现的演讲，以及在生物标志物发现、体外药物发现的电脑模拟运用和免疫疗法毒理学评估平台等领域的进一步科学演讲。“尽管我们面临全球性的挑战，我们仍致力于推动科学探讨和药物发现。”中美冠科市场营销执行总监Gavin Cooper表示。“我们的创新活动体验旨在尽可能接近实际会议体验，能够实时访问我们的所有资源、海报和科学团队。”此次活动还设有一个科学性的线上休息室，用于提问和与我们的科学团队进行实时交流。并在展位上提供了大量中美冠科的资源，展示了包括类器官、生物标志物发现、生物信息学和人源肿瘤异体移植 (PDX)模型在内的产品和服务。此次免费活动可以在CrownBio.com/AACR20上注册。关于中美冠科中美冠科生物技术有限公司（CrownBio）隶属于JSR生命科学公司，是一家全球性的药物发现和开发公司，为推进肿瘤、炎症、心血管及代谢疾病的研究提供转化医学平台。中美冠科拥有数量庞大的相关模型库和预测工具组合，能够为客户提供优秀的临床候选药物筛选服务。有关详细信息，请访问：https://www.crownbio.comhttps://www.jsrlifesciences.comMedia Enquiries:Crown BioscienceJody Barbeaupr@crownbio.comhttps://www.globenewswire.com/NewsRoom/AttachmentNg/2e34cb8b-be2b-4be4-b596-1e33d74cd138

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.